Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

AML1 overexpression and/or mutations should be checked in trisomy 21 patients with megakaryocytic leukemia

Leukemia volume 17, page 1421 (2003)Cite this article

TO THE EDITOR

Some years ago, we hypothesised that a gene implicated in megakaryocytic progenitor maturation and/or differentiation should sit in chromosome 21, and AML1 was noted as a candidate gene.1

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Huret JL, Léonard C . Chromosome 21 and platelets: a gene dosage effect. Clin Genet 1997; 51: 140–141.

    Article  CAS  Google Scholar 

  2. Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 2002; 99: 1364–1372.

    Article  CAS  Google Scholar 

  3. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 134–135.

    Article  Google Scholar 

  4. Buijs A, Poddighe P, van Wijk R, van Solinge W, Borst E, Verdonck L et al. A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies. Blood 2001; 98: 2856–2858.

    Article  CAS  Google Scholar 

  5. Huret JL . AML1. Atlas Genet Cytogenet Oncol Haematol Jan 2003. URL http://www.infobiogen.fr/services/chromcancer/Genes/AML1.html.

  6. Blake T, Adya N, Kim CH, Oates AC, Zon L, Chitnis A et al. Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis. Blood 2000; 96: 4178–4184.

    CAS  PubMed  Google Scholar 

  7. Hall MA, Curtis DJ, Metcalf D, Elefanty AG, Sourris K, Robb L et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 2003; 100: 992–997.

    Article  CAS  Google Scholar 

  8. Zipursky A, Thorner P, De Harven E, Christensen H, Doyle J . Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. Leukemia Res 1994; 18: 163–171.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Information, Genetics, UMR 1599 CNRS, University Hospital, Poitiers, France

    J L Huret & C Léonard

Authors
  1. J L Huret
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Léonard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huret, J., Léonard, C. AML1 overexpression and/or mutations should be checked in trisomy 21 patients with megakaryocytic leukemia. Leukemia 17, 1421 (2003). https://doi.org/10.1038/sj.leu.2402984

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402984

Search

Advanced search

Quick links